
Research into Alzheimer’s disease has led to the development of biomarkers in recent years that greatly improve diagnostic accuracy.
Until recently, confirming that someone’s symptoms were caused by Alzheimer’s required invasive or costly tests, such as a PET scan (nuclear medicine) or analysis of the cerebrospinal fluid by lumbar puncture.
Today, a blood test measuring the p-tau217 protein, a highly specific and sensitive biomarker of Alzheimer’s pathology, can show with great reliability whether a person’s symptoms are due to this disease or not, even in its early stages.
Who is the p-tau217 test for?
The test is mainly indicated for people with symptoms:
- Memory or other cognitive complaints that are new or getting worse.
- Mild cognitive impairment.
- Early-stage dementia whose cause is unclear.
It is not routinely recommended for people without symptoms, even if they are over 60 or have a family history of Alzheimer’s. A positive result in someone without symptoms cannot tell whether or when the disease will develop, and may cause unnecessary worry. That is why the test is always requested after a consultation with a neurologist.
A key part of assessing anti-amyloid treatments
The new treatments for Alzheimer’s, known as anti-amyloid treatments, are only indicated for selected patients in the early stages of the disease. Before starting them, the presence of amyloid protein must be confirmed, and biomarkers are one of the criteria used to assess whether a person is a suitable candidate, together with the clinical assessment, cognitive testing and an MRI scan.
Why early diagnosis matters
- It helps you understand what is happening and plan ahead.
- It allows treatments that are only indicated in the early stages to be considered.
- If the result is negative, it helps rule out Alzheimer’s and look for other causes, some of them treatable.
How we do it at NeuroProtect
At our clinic in Estepona, biomarker testing is requested and interpreted as part of a full neurological assessment: a consultation with a neurologist specialised in cognitive impairment, a neuropsychological assessment and, when needed, an MRI scan. Read more on our pages about Alzheimer’s blood biomarkers and Alzheimer’s disease.
If you or a family member have noticed memory problems, you can book an appointment online or call us on +34 951 955 189. We see patients in English and Spanish.
This article is for information only and does not replace an assessment by a healthcare professional.